Jeffrey Lipman Selected Research

Anti-Bacterial Agents (Antibiotics)

3/2022	Use of Antimicrobials for Bloodstream Infections in the Intensive Care Unit, a Clinically Oriented Review.
1/2022	Plasmid-Mediated Ciprofloxacin Resistance Imparts a Selective Advantage on Escherichia coli ST131.
12/2021	A personalised approach to antibiotic pharmacokinetics and pharmacodynamics in critically ill patients.
7/2021	Development and validation of a UHPLC-MS/MS method to measure cefotaxime and metabolite desacetylcefotaxime in blood plasma: a pilot study suitable for capillary microsampling in critically ill children.
5/2021	A Multicenter Observational Study Evaluating Outcomes Associated With Antibiotic Combination Versus Monotherapy in Patients With Septic Shock.
4/2021	A narrative review on antimicrobial therapy in septic shock: updates and controversies.
1/2021	Initial antimicrobial management of sepsis.
1/2021	The Effect of Renal Replacement Therapy and Antibiotic Dose on Antibiotic Concentrations in Critically Ill Patients: Data From the Multinational Sampling Antibiotics in Renal Replacement Therapy Study.
1/2021	Evaluation of Meropenem-Ciprofloxacin Combination Dosage Regimens for the Pharmacokinetics of Critically Ill Patients With Augmented Renal Clearance.
1/2021	Optimising Treatment Outcomes for Children and Adults Through Rapid Genome Sequencing of Sepsis Pathogens. A Study Protocol for a Prospective, Multi-Centre Trial (DIRECT).

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Jeffrey Lipman Research Topics

Disease

179	Critical Illness (Critically Ill) 06/2022 - 09/2004
92	Infections 01/2022 - 07/2007
63	Sepsis (Septicemia) 06/2022 - 07/2005
24	Septic Shock (Toxic Shock Syndrome) 06/2022 - 03/2007
22	Acute Kidney Injury (Acute Renal Failure) 01/2021 - 09/2004
20	Body Weight (Weight, Body) 01/2022 - 03/2007
18	Burns 01/2021 - 07/2007
12	AIDS-Related Complex (ARC) 01/2021 - 01/2010
11	Pneumonia (Pneumonitis) 09/2021 - 12/2009
10	Peritonitis 01/2022 - 03/2007
9	Wounds and Injuries (Trauma) 07/2021 - 12/2008
8	Obesity 07/2021 - 02/2013
7	Inflammation (Inflammations) 12/2020 - 06/2011
6	Shock 06/2022 - 12/2008
5	Ventilator-Associated Pneumonia 03/2022 - 03/2008
5	Intraabdominal Infections 01/2022 - 03/2007
5	Bacterial Infections (Bacterial Infection) 06/2021 - 01/2017
5	Drug-Related Side Effects and Adverse Reactions 09/2016 - 10/2010
4	Communicable Diseases (Infectious Diseases) 09/2021 - 04/2009
4	Traumatic Brain Injuries (Traumatic Brain Injury) 01/2021 - 12/2010
4	Hematologic Neoplasms (Hematological Malignancy) 07/2019 - 06/2014
4	Healthcare-Associated Pneumonia 03/2019 - 09/2010
4	Renal Insufficiency (Renal Failure) 10/2014 - 12/2008
3	Bacteremia 03/2022 - 01/2009
3	Meningitis 12/2020 - 04/2009
3	Hypoalbuminemia 01/2020 - 10/2014
3	Fever (Fevers) 07/2019 - 07/2007
3	Pulmonary Embolism 01/2019 - 12/2017
3	Surgical Wound Infection 04/2017 - 02/2011
3	Chronic Renal Insufficiency 01/2017 - 03/2014
3	Invasive Candidiasis 12/2016 - 11/2011
2	Hypoaldosteronism (Hyporeninemic Hypoaldosteronism) 06/2022 - 01/2020
2	Respiratory Insufficiency (Respiratory Failure) 11/2021 - 01/2020
2	Urinary Tract Infections (Urinary Tract Infection) 01/2021 - 01/2005
2	Seizures (Absence Seizure) 01/2021 - 12/2012
2	Pseudomonas Infections 01/2020 - 01/2018
2	Heart Failure 12/2019 - 12/2018

Drug/Important Bio-Agent (IBA)

124	Anti-Bacterial Agents (Antibiotics)IBA 03/2022 - 02/2007
59	Pharmaceutical PreparationsIBA 01/2022 - 08/2008
30	Meropenem (Merrem)FDA LinkGeneric 03/2022 - 04/2009
29	LactamsIBA 10/2020 - 06/2012
27	CreatinineIBA 01/2021 - 03/2009
25	Tazobactam Drug Combination Piperacillin (Zosyn)FDA LinkGeneric 01/2022 - 07/2007
20	Vancomycin FDA LinkGeneric 11/2020 - 09/2004
19	Piperacillin FDA LinkGeneric 03/2022 - 03/2008
17	beta-LactamsIBA 01/2018 - 07/2007
10	beta Lactam AntibioticsIBA 10/2016 - 07/2007
9	AminoglycosidesIBA 03/2021 - 01/2006
9	Fluconazole (Zonal)FDA LinkGeneric 11/2016 - 01/2005
7	Ceftriaxone (Ceftriaxon)FDA LinkGeneric 01/2022 - 02/2007
6	Gentamicins (Gentamicin)FDA LinkGeneric 01/2022 - 12/2009
6	Carbapenems (Carbapenem Antibiotics)IBA 08/2021 - 04/2009
6	Amikacin (A.M.K)FDA LinkGeneric 06/2021 - 01/2015
6	Fosfomycin FDA Link 03/2019 - 10/2013
6	Cefazolin (Ancef)FDA LinkGeneric 07/2016 - 02/2011
5	Biomarkers (Surrogate Marker)IBA 01/2021 - 06/2011
5	Ciprofloxacin (Cipro)FDA LinkGeneric 01/2021 - 07/2005
5	Anti-Infective Agents (Microbicides)IBA 01/2021 - 12/2010
5	Antifungal AgentsIBA 05/2020 - 11/2011
5	Proteins (Proteins, Gene)FDA Link 01/2020 - 08/2010
5	Cefepime (Maxipime)FDA LinkGeneric 12/2012 - 02/2007
4	Dialysis SolutionsIBA 01/2022 - 09/2004
4	Methicillin (Metin)FDA Link 10/2014 - 10/2011
3	Tobramycin (Nebcin)FDA LinkGeneric 01/2022 - 01/2018
3	Caspofungin (Cancidas)FDA Link 01/2022 - 02/2015
3	Micafungin (FK463)FDA Link 12/2021 - 01/2021
3	tazobactam drug combination ceftolozaneIBA 01/2021 - 12/2019
3	Floxacillin (Flucloxacillin)IBA 01/2020 - 08/2010
3	Tazobactam FDA LinkGeneric 10/2019 - 02/2010
3	posaconazole FDA Link 06/2019 - 01/2018
3	Ceftazidime (Fortum)FDA LinkGeneric 03/2019 - 02/2007
3	Blood Proteins (Serum Proteins)IBA 01/2018 - 07/2009
3	Brain Natriuretic Peptide (Natrecor)FDA Link 10/2016 - 11/2013
3	Doripenem FDA Link 01/2016 - 02/2013
3	Cephalothin (Cefalotin)FDA Link 12/2009 - 07/2007
2	ReninIBA 06/2022 - 01/2020
2	FludrocortisoneIBA 06/2022 - 01/2020
2	Hydrocortisone (Cortisol)FDA LinkGeneric 06/2022 - 03/2007
2	MineralocorticoidsIBA 06/2022 - 01/2020
2	GlucocorticoidsIBA 06/2022 - 01/2020
2	Angiotensin IIIBA 06/2022 - 01/2020
2	Cefotaxime (Kendrick)FDA LinkGeneric 01/2022 - 07/2021
2	desacetylcefotaximeIBA 01/2022 - 07/2021
2	AlbuminsIBA 09/2021 - 01/2020
2	A 7 (A-7)IBA 01/2021 - 12/2009
2	ProcalcitoninIBA 01/2021 - 09/2014
2	SolutionsIBA 01/2020 - 09/2004
2	Mycophenolic Acid (Cellcept)FDA LinkGeneric 12/2019 - 08/2013

Therapy/Procedure

62	Therapeutics 03/2022 - 01/2005
28	Critical Care (Surgical Intensive Care) 01/2022 - 07/2005
28	Renal Replacement Therapy (Therapies, Renal Replacement) 01/2021 - 11/2011
21	Continuous Renal Replacement Therapy 12/2021 - 09/2004
9	Resuscitation 01/2022 - 03/2007
9	Length of Stay 01/2021 - 02/2007
8	Artificial Respiration (Mechanical Ventilation) 01/2021 - 07/2007
6	Peritoneal Dialysis 01/2022 - 12/2009
5	Mechanical Ventilators (Ventilator) 03/2022 - 01/2018
5	Extracorporeal Membrane Oxygenation 11/2021 - 10/2012
3	Ventriculostomy 12/2020 - 01/2015
2	Antibiotic Prophylaxis 07/2021 - 07/2007